Using infrared cameras to help detect juvenile arthritis in kids

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates infrared thermography as a non-invasive imaging tool for detecting joint inflammation in pediatric patients with suspected or established juvenile idiopathic arthritis. Participants undergo clinical examination, routine blood work, and an infrared camera session at baseline, 1 month, and 3 months, with a control group receiving a single thermography session plus basic blood work. The study compares thermography results to clinical scores, laboratory markers, and ultrasound Doppler to determine diagnostic accuracy and potential as a complementary monitoring method. The approach aims to offer a child-friendly, radiation-free option that could streamline assessment in pediatric rheumatology. Data collected will describe the agreement between IRT findings and standard assessments over time.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* children aged 2-16 years with clinically suspected arthritis affecting the knee, ankle, wrist, or hand, irrespective of disease stage,
* control group : children with non-inflammatory conditions and no history of autoimmune or inflammatory disease.

Exclusion Criteria:

* other inflammatory or non-inflammatory diseases or recent trauma/surgery explaining joint symptoms,
* local skin conditions interfering with infrared imaging, and treatments or comorbidities likely to alter joint or body temperature.

Where it's running

• CHRU Amiens
  Amiens, France Recruiting

Study contacts

• Study coordinator: Djamal-Dine DJEDDI, Pr
• Email: Djeddi.Djamal-Dine@chu-amiens.fr
• Phone: 33+322035590

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oral health, saliva bacteria, and disease activity in children with JIA

  This study checks if how active juvenile idiopathic arthritis is relates to oral health in children who already receive rheumatology care.

  Recruiting Shanghai Jiao Tong University School of Medicine · Shanghai, Pudongxinqu · NCT07799831

• Automated Echocardiography Measurements Using Deep-Learning Software

  This study tests whether US2.AI can automatically measure heart structure and function from standard echocardiograms as accurately as expert clinicians in adults.

  Recruiting Centro Cardiologico Monzino · Milan, Lombardy · NCT07738419

• AI blind-sweep obstetric ultrasound by non-specialists in rural DRC

  Researchers test an AI-assisted blind-sweep ultrasound to screen pregnant women in rural Democratic Republic of Congo, using non-specialist health workers.

  Recruiting SOIK Corporation Sarl · Kenge, Kwango · NCT07677670

• Timing of AI Help in Chest X-Rays: Does When AI Becomes Visible Change How Clinicians Read Images?

  Doctors test chest X-ray interpretation with AI information shown either before or after they start reviewing the image to see how timing affects their search patterns and decisions.

  Recruiting University Hospitals, Leicester · Leicester, Leicestershire · NCT07675694

• Olokizumab treatment for children with polyarticular juvenile idiopathic arthritis

  This test gives weight-based doses of olokizumab every 4 weeks to see if it helps control polyarticular juvenile idiopathic arthritis and is safe for children aged 2–17.

  Recruiting at 14 sites Phase 2 R-Pharm · Kazan' and 13 other locations · NCT07517575

• Post-marketing surveillance of Cosentyx (secukinumab) for hidradenitis suppurativa, pediatric plaque psoriasis, and juvenile idiopathic arthritis in Korea

  This study will see how Cosentyx (secukinumab) works and is tolerated in people in Korea with moderate-to-severe hidradenitis suppurativa, pediatric plaque psoriasis, or juvenile idiopathic arthritis who are being treated in routine care.

  Recruiting Novartis · Seoul, Seoul · NCT07243782

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.